Evidence map›Paper›PMID 25124441›Full record

ArticleScience (New York, N.Y.)2014

Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.

Mark J Hoegger, Anthony J Fischer, James D McMenimen, Lynda S Ostedgaard, Alex J Tucker, Maged A Awadalla, Thomas O Moninger, Andrew S Michalski, Eric A Hoffman, Joseph Zabner and 2 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Science (New York, N.Y.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 234 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
234citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04551040 phase1active not recruitingnot on this mapstarted 2021, after this paper: background citation

Assessing Target Engagement of Terazosin in Healthy Adults

TypeinterventionalSponsorUniversity of IowaRan2021 to 2025Enrolled18ConditionsHealthyArmsTerazosin
NCT05392855 naterminatednot on this mapstarted 2023, after this paper: background citation

Symptom Based Performance of Airway Clearance Therapy After Starting Highly Effective CFTR Modulator Therapy for Cystic Fibrosis

TypeinterventionalSponsorUniversity of Missouri-ColumbiaRan2023 to 2024Enrolled6ConditionsCystic Fibrosis, Mucociliary Clearance DefectArmsSymptom driven performance of airway clearance, Continuous daily performance of airway clearance
3 · Its place in the literature

Who cites it

234 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Antiviral defenses are diminished at birth in cystic fibrosis pig airways.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2026
    Article
  6. Article
  7. Structural and cellular mechanisms of mucus plugging in the larger airways.Chinese medical journal pulmonary and critical care medicine · 2026
    Review
  8. Considerations for early life genetic therapies in cystic fibrosis.American journal of physiology. Lung cellular and molecular physiology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. The pH-sensitive translocation of V-ATPase in the small airway of cystic fibrosis pigs.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  17. Mucociliary clearance is impaired in small airways of cystic fibrosis pigs.American journal of physiology. Lung cellular and molecular physiology · 2024
    Article
  18. The lysogenic filamentousPNAS nexus · 2024
    Article
  19. Development and Initial Characterization of Pigs withbioRxiv : the preprint server for biology · 2024
    Article
  20. Article

174 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Mark J HoeggerDepartment of Molecular Physiology and Biophysics, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Anthony J FischerDepartment of Pediatrics, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
James D McMenimenDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Lynda S OstedgaardDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Alex J TuckerDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Maged A AwadallaDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Thomas O MoningerCentral Microscopy Research Facility, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Andrew S MichalskiDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
Eric A HoffmanDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. Department of Radiology, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA.
Joseph ZabnerDepartment of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA.
David A StoltzDepartment of Molecular Physiology and Biophysics, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. Department of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. Department of Biomedical Engineering, University of Iowa, Iowa City, IA 52242, USA. david-stoltz@uiowa.edu michael-welsh@uiowa.edu.
Michael J WelshDepartment of Molecular Physiology and Biophysics, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. Department of Internal Medicine, University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. Howard Hughes Medical Institute (HHMI), University of Iowa, Roy J. and Lucille A. Carver College of Medicine, Iowa City, IA 52242, USA. david-stoltz@uiowa.edu michael-welsh@uiowa.edu.

Funding

Vector CoreP01HL051670 · NHLBI · UNIVERSITY OF IOWA · PI MEYERHOLZ, DAVID K · 1993 to 2019
$36.5M
Respiratory virus infection in early cystic fibrosis lung diseaseP01HL091842 · NHLBI · UNIVERSITY OF IOWA · PI ZABNER, JOSEPH · 2008 to 2022
$34.2M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007337 · NIGMS · UNIVERSITY OF IOWA · PI GEYER, PAMELA K., LENTZ, STEVEN R · 1985 to 2020
$15.9M
Airway Goblet Cells: Friend or Foe?DP2HL117744 · NHLBI · UNIVERSITY OF IOWA · PI STOLTZ, DAVID A · 2012 to 2012
$2.3M
Howard Hughes Medical InstituteNCCDPHP CDC HHS DP2 HL117744NHLBI NIH HHS DP2 HL117744NHLBI NIH HHS HL051670NHLBI NIH HHS HL091842NHLBI NIH HHS P01 HL051670NHLBI NIH HHS P01 HL091842NIDDK NIH HHS DK054759NIDDK NIH HHS P30 DK054759NIGMS NIH HHS T32 GM007337
6 · The paper itself

Abstract

Lung disease in people with cystic fibrosis (CF) is initiated by defective host defense that predisposes airways to bacterial infection. Advanced CF is characterized by a deficit in mucociliary transport (MCT), a process that traps and propels bacteria out of the lungs, but whether this deficit occurs first or is secondary to airway remodeling has been unclear. To assess MCT, we tracked movement of radiodense microdisks in airways of newborn piglets with CF. Cholinergic stimulation, which elicits mucus secretion, substantially reduced microdisk movement. Impaired MCT was not due to periciliary liquid depletion; rather, CF submucosal glands secreted mucus strands that remained tethered to gland ducts. Inhibiting anion secretion in non-CF airways replicated CF abnormalities. Thus, impaired MCT is a primary defect in CF, suggesting that submucosal glands and tethered mucus may be targets for early CF treatment.

Indexed as

Mucociliary ClearanceAnimalsAnimals, NewbornAnionsCiliaCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalExocrine GlandsLungMethacholine ChlorideMucusRespiratory MucosaRespiratory SystemSwineTracheaAnionsCystic Fibrosis Transmembrane Conductance RegulatorMethacholine Chloride

Identifiers

PMID25124441
PMCPMC4346163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.